268 related articles for article (PubMed ID: 9121155)
1. Survival benefit of extended D2 resection for proximal gastric cancer.
Volpe CM; Driscoll DL; Miloro SM; Douglass HO
J Surg Oncol; 1997 Mar; 64(3):231-6. PubMed ID: 9121155
[TBL] [Abstract][Full Text] [Related]
2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
4. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.
Lam S; Tan E; Menezes A; Martin D; Gallagher J; Storey D; Sandroussi C
World J Surg Oncol; 2018 Jul; 16(1):136. PubMed ID: 29986713
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
7. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
8. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
Yildirim E; Celen O; Berberoglu U
J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
[TBL] [Abstract][Full Text] [Related]
10. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
11. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification.
Roukos D; Schmidt-Mathiesen A; Encke A
Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
16. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
18. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
19. The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study.
Huang CM; Chen T; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
Surg Endosc; 2017 Mar; 31(3):1383-1392. PubMed ID: 27450211
[TBL] [Abstract][Full Text] [Related]
20. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
